Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $19324.0.

  • Onconetix's Other Accumulated Expenses fell 9122.96% to $19324.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19324.0, marking a year-over-year decrease of 9122.96%. This contributed to the annual value of $40000.0 for FY2024, which is 8495.39% down from last year.
  • Onconetix's Other Accumulated Expenses amounted to $19324.0 in Q3 2025, which was down 9122.96% from $11171.0 recorded in Q2 2025.
  • Onconetix's 5-year Other Accumulated Expenses high stood at $640241.0 for Q1 2024, and its period low was $11171.0 during Q2 2025.
  • In the last 3 years, Onconetix's Other Accumulated Expenses had a median value of $134261.0 in 2023 and averaged $174473.2.
  • Per our database at Business Quant, Onconetix's Other Accumulated Expenses tumbled by 2551.82% in 2024 and then tumbled by 9122.96% in 2025.
  • Over the past 3 years, Onconetix's Other Accumulated Expenses (Quarter) stood at $265849.0 in 2023, then tumbled by 84.95% to $40000.0 in 2024, then tumbled by 51.69% to $19324.0 in 2025.
  • Its Other Accumulated Expenses stands at $19324.0 for Q3 2025, versus $11171.0 for Q2 2025 and $139082.0 for Q1 2025.